Healthcare Cross-Border M&A Between China, Israel and Russia

The global pandemic has forced the healthcare sector to reassess its approach to operations and its outlook for future transformations. M&A activity in the sector has slowed down, however, we can still see shorter-term deal tactics on the market. These will most probably be followed by more fundamental changes in deal strategies.

On September 15, at 11 am UTC+3 (4 pm Beijing time), we have organized an international webinar to discuss topics related to cross-border M&A in healthcare from the perspective of the following countries, China, Israel, Russia.

Agenda

  • The prospective market situation of healthcare M&A in China, Israel and Russia.
  • What are the key drivers and underlying motivations of buyers and sellers in three countries? What are the key success factors?
  • Which key legal and regulatory considerations do healthcare companies need to make when undertaking transactions? Especially in the current situation.
  • Which elements are key to M&A success in the sector?
  • What are the potential trends or other key elements likely to impact at a market level?

Speakers

See More
China

Carl Xiao

SVP of SPH HK Investment, Assistant GM of SPH-BIOCAD (HK) Limited
See More
Israel

Oren Gez

Founder of Eight Bridges Consulting
See More
China

Alvin Syh

CEO of Anrich Capital, CEO of BC Asset Management
See More
Russia

Dmitry Sidorov

Horizons Country Partner – Russia, Head of the Corporate and International Department CPO Group LLC
See More
China

Ruilin Zhao, Ph.D

Partner at CD Capital
See More
Russia

Aleksandr Lobakov

Managing Partner in Novus Capital
See More
China

John Yuan

Head of M&A Community China

Agenda

Get In Touch

Our team is happy to answer your questions. Fill out this form and we will get in touch with you.